Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).
- Status
- COMPLETED
- Phase
- N/A
The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
- Status
- COMPLETED
- Phase
- NA
Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism
- Status
- COMPLETED
- Phase
- N/A
Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
- Status
- COMPLETED
- Phase
- N/A
Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet
- Status
- COMPLETED
- Phase
- PHASE1
Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Long-Term Retention of Gadolinium in Bone
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
The Influence of Peripheral Androgen Conversion at Women Adult Acne
- Status
- UNKNOWN
- Phase
- NA
Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
- Status
- COMPLETED
- Phase
- PHASE1
Regorafenib Post-marketing Surveillance
- Status
- COMPLETED
- Phase
- N/A
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China
- Status
- COMPLETED
- Phase
- N/A
Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
- Status
- COMPLETED
- Phase
- PHASE3
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
- Status
- COMPLETED
- Phase
- N/A
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
- Status
- COMPLETED
- Phase
- PHASE3
HIGH Altitude CArdiovascular REsearch in the ANDES
- Status
- COMPLETED
- Phase
- PHASE4
Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients
- Status
- COMPLETED
- Phase
- PHASE3